Metabolic challenges and interventions in CAR T cell therapy

Area of Science:

• Immunotherapy
• Cancer Biology
• Metabolic Engineering

Background:

• Chimeric antigen receptor (CAR) T-cell therapy has revolutionized hematological malignancy treatment.
• Significant challenges hinder CAR T-cell efficacy against solid tumors, primarily due to the tumor microenvironment.
• Understanding these limitations is key to advancing CAR T-cell applications.

Purpose of the Study:

• To review the metabolic challenges faced by CAR T cells in the tumor microenvironment.
• To explore novel strategies for metabolic reprogramming in CAR T-cell manufacturing.
• To discuss approaches for enhancing CAR T-cell metabolic adaptability for improved antitumor responses.

Main Methods:

• Literature review of CAR T-cell therapy in solid tumors.
• Analysis of metabolic stress and signaling within the tumor microenvironment.
• Examination of intrinsic and extrinsic factors affecting CAR T-cell function.
• Review of metabolic engineering strategies for CAR T-cell optimization.

Main Results:

• Metabolic stress and signaling in the tumor microenvironment significantly restrict CAR T-cell efficacy.
• Intrinsic and extrinsic factors within solid tumors present obstacles to CAR T-cell function.
• Novel approaches are being developed to target and rewire CAR T-cell metabolic programming.
• Strategies to improve metabolic adaptability can enhance CAR T-cell potency and survival.

Conclusions:

• Overcoming metabolic hurdles in the tumor microenvironment is critical for successful CAR T-cell therapy in solid tumors.
• Metabolic reprogramming and enhanced adaptability are key to improving CAR T-cell performance.
• Further research into metabolic strategies holds promise for expanding CAR T-cell applications in oncology.